Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nipro Corporation (8086:JPX), powered by AI.
Nipro Corporation is currently trading at ¥1,477. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Nipro Corporation on Alpha Lenz.
Nipro Corporation's P/E ratio is 47.1.
“Nipro Corporation trades at a P/E of 47.1 (premium valuation) with modest ROE of 2.1%.”
Ask for details →Nipro Corporation is a diversified healthcare company that plays a vital role in the medical and pharmaceutical industries worldwide. Primarily focused on the development and distribution of medical devices, pharmaceuticals, and pharmaceutical packaging, Nipro serves as a critical supplier for hospitals, clinics, and research institutions. The company's medical device segment includes dialysis products, injection and infusion systems, and cardiovascular equipment, underscoring its significance in life-saving healthcare technologies. Additionally, Nipro manufactures pharmaceutical products such as generic drugs, which contribute to cost-effective healthcare solutions. In the pharmaceutical packaging domain, the company offers diverse options for storage and safe consumption of medications, affecting logistics and safety across the pharmaceutical industry. Headquartered in Osaka, Japan, Nipro's extensive product portfolio and global distribution network emphasize its commitment to advancing healthcare outcomes and improving patient care efficiency. By supporting crucial medical infrastructure, Nipro Corporation holds a fundamental position in ensuring the operational effectiveness of healthcare providers around the world.
“Nipro Corporation trades at a P/E of 47.1 (premium valuation) with modest ROE of 2.1%.”
Ask for details →